Legend Biotech Corporation (LEGN) Balance Sheet
LEGN balance sheet, 2025
December 31, 2025 · U.S. dollars$1.73B assets = $731.6M liabilities + $1.00B equity
Both columns are drawn to the same scale: what LEGN owns equals what it owes plus shareholders’ equity. Hover a block for its value.
LEGN financial health
Descriptive bands, not a rating. Fiscal 2025.
LEGN balance sheet trends, 2017–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $238.7M2017 | $1.73B2025 | +28.1%/yr | |
| Total liabilities | $226.5M2017 | $731.6M2025 | +15.8%/yr | |
| Shareholders’ equity | $12.2M2017 | $1.00B2025 | +73.6%/yr | |
| Cash & short-term investments | $2.1M2017 | $948.6M2025 | +114.5%/yr | |
| Total debt | $269,0002017 | $413.7M2025 | +150.2%/yr | |
| Net cash (debt) | $1.8M2017 | $534.9M2025 | +$533.1M | |
| Working capital | $178.8M2017 | $610.7M2025 | +$431.9M | |
| Book value per share | $0.092017 | $5.442025 | +66.5%/yr | |
| Current ratio | 4.432017 | 1.962025 | −2.47 | |
| Debt / equity | 0.022017 | 0.412025 | +0.39 | |
| Shares outstanding | 132.0M2017 | 184.3M2025 | +4.3%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
LEGN assets
LEGN liabilities and equity
LEGN debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
LEGN balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & short-term investments | $948.6M | $1.12B | $1.31B | $1.03B | $882.4M | $506.1M | $158.9M | $216.2M | $2.1M |
| Cash & equivalents | $901.9M | $286.7M | $1.28B | $786.0M | $688.9M | $456.1M | $83.4M | $210.2M | $2.1M |
| Short-term investments | $46.7M | $835.9M | $31.0M | $239.6M | $193.5M | $50.0M | $75.6M | $6.0M | — |
| Receivables | $250.3M | $124.9M | $157.1M | $44.5M | $58.5M | $82.6M | $35.8M | $108.6M | $228.7M |
| Inventory | $32.0M | $23.9M | $19.4M | $10.4M | $1.7M | $1.8M | $1.2M | $1.1M | $11,000 |
| Other current assets | $16.2M | $12.4M | $12.6M | $18.6M | $7.2M | $3.5M | $11.3M | $1.1M | $31,000 |
| Total current assets | $1.25B | $1.28B | $1.50B | $1.10B | $949.9M | $593.9M | $207.1M | $327.0M | $230.9M |
| Property, plant & equipment (net) | $402.0M | $201.6M | $189.7M | $161.7M | $143.0M | $112.1M | $75.5M | $33.1M | $2.9M |
| Goodwill & intangible assets | $74.6M | $174.2M | $4.1M | $68.7M | $16.8M | −$2.0M | $5.1M | $49,000 | $2,000 |
| Long-term investments | $5.0M | $4.4M | $4.4M | $0 | $4.7M | $0 | $0 | $0 | $0 |
| Other non-current assets | $5.0M | $6.1M | $152.7M | $1.5M | $5.1M | $18.0M | $0 | $68.9M | $4.9M |
| Total assets | $1.73B | $1.67B | $1.85B | $1.33B | $1.12B | $722.1M | $287.7M | $429.0M | $238.7M |
| Liabilities | |||||||||
| Accounts payable | $81.2M | $37.2M | $20.2M | $31.7M | $7.0M | $4.9M | $9.6M | $7.3M | $4.3M |
| Short-term debt | $326.5M | $4.8M | $3.2M | $3.6M | $911,000 | $1.8M | $1.0M | $373,000 | $64,000 |
| Deferred revenue | $11.3M | $47.4M | $53.0M | $451,000 | $304,000 | $55.0M | $46.3M | $40.3M | $30.2M |
| Total current liabilities | $636.4M | $277.6M | $216.4M | $297.8M | $229.2M | $115.6M | $127.8M | $159.2M | $52.1M |
| Long-term debt | $0 | $301.2M | $281.3M | $260.9M | $120.5M | $0 | $5.1M | $3.9M | $205,000 |
| Lease obligations | $94.6M | $49.4M | $47.3M | $23.6M | $2.5M | $3.4M | $6.1M | $4.3M | — |
| Other long-term liabilities | $95.2M | $50.8M | $99.5M | $27.9M | $3.9M | $6.7M | $277.7M | $257.3M | $174.2M |
| Total liabilities | $731.6M | $629.6M | $597.2M | $586.7M | $353.5M | $122.3M | $410.6M | $420.4M | $226.5M |
| Shareholders' equity | |||||||||
| Common stock & paid-in capital | $100,000 | $37,000 | $36,000 | $33,000 | $31,000 | $27,000 | $20,000 | $20,000 | $20,000 |
| Retained earnings (deficit) | −$1.96B | −$1.66B | −$1.48B | −$966.5M | −$520.1M | −$116.5M | −$127.3M | $5.7M | $8.5M |
| Accumulated other comprehensive income | $122.2M | −$68.2M | $98.9M | $14.7M | $4.9M | $6.0M | −$122.9M | $8.6M | −$236,000 |
| Total shareholders' equity | $1.00B | $1.04B | $1.25B | $744.3M | $765.9M | $597.8M | −$122.9M | $8.6M | $12.2M |
| Key figures | |||||||||
| Total debt | $413.7M | $350.6M | $328.7M | $284.5M | $123.0M | $3.7M | $6.1M | $4.3M | $269,000 |
| Net cash (debt) | $534.9M | $772.1M | $980.0M | $741.1M | $759.4M | $502.4M | $152.8M | $211.9M | $1.8M |
| Working capital | $610.7M | $1.01B | $1.28B | $801.3M | $720.6M | $478.4M | $79.3M | $167.8M | $178.8M |
| Tangible book value | $927.5M | $866.3M | $1.25B | $675.6M | $749.1M | $599.8M | −$128.0M | $8.6M | $12.2M |
| Book value per share | $5.44 | $5.69 | $7.11 | $4.68 | $5.44 | $5.06 | −$0.93 | $0.09 | $0.09 |
| Shares outstanding | 184.3M | 182.9M | 176.1M | 159.0M | 140.9M | 118.2M | 132.0M | 100.2M | 132.0M |
| Current ratio | 1.96 | 4.62 | 6.92 | 3.69 | 4.14 | 5.14 | 1.62 | 2.05 | 4.43 |
| Quick ratio | 1.88 | 4.49 | 6.77 | 3.59 | 4.11 | 5.09 | 1.52 | 2.04 | 4.43 |
| Debt / equity | 0.41 | 0.34 | 0.26 | 0.38 | 0.16 | 0.01 | — | 0.50 | 0.02 |
| Equity / assets | 57.8% | 62.3% | 67.7% | 55.9% | 68.4% | 82.8% | −42.7% | 2.0% | 5.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $964.6M | $834.6M | $948.6M | $992.6M | $967.6M | $1.01B | $1.12B | $1.21B | $1.29B | $1.30B | $1.31B | $1.42B |
| Cash & equivalents | $672.9M | $646.4M | $901.9M | $278.9M | $266.6M | $441.7M | $286.7M | $459.3M | $201.3M | $897.6M | $1.28B | $963.5M |
| Short-term investments | $291.7M | $188.2M | $46.7M | $713.7M | $701.0M | $563.7M | $835.9M | $753.1M | $1.09B | $404.8M | $31.0M | $460.4M |
| Receivables | $198.0M | $186.6M | $250.3M | $202.6M | $229.0M | $166.8M | $124.9M | $104.0M | $101.4M | $78.0M | $157.1M | $49.7M |
| Inventory | $41.5M | $37.1M | $32.0M | $29.2M | $35.6M | $30.9M | $23.9M | $23.5M | $18.9M | $22.1M | $19.4M | $18.0M |
| Other current assets | $23.3M | $24.4M | $16.2M | $17.7M | $17.7M | $15.6M | $12.4M | $10.1M | $12.7M | $11.3M | $12.6M | $17.3M |
| Total current assets | $1.23B | $1.08B | $1.25B | $1.24B | $1.25B | $1.22B | $1.28B | $1.35B | $1.42B | $1.41B | $1.50B | $1.51B |
| Property, plant & equipment (net) | $448.2M | $452.5M | $402.0M | $253.7M | $233.6M | $206.6M | $201.6M | $203.9M | $220.0M | $186.0M | $189.7M | $184.7M |
| Goodwill & intangible assets | $49.8M | $35.0M | $74.6M | $206.2M | $200.8M | $184.7M | $174.2M | $175.5M | $147.3M | $169.5M | $4.1M | $140.0M |
| Long-term investments | $0 | $0 | $5.0M | $0 | $0 | $0 | $4.4M | $4.5M | $4.4M | $4.4M | $4.4M | $4.3M |
| Other non-current assets | $25.5M | $26.5M | $5.0M | $11.0M | $5.7M | $5.6M | $6.1M | $1.9M | $1.6M | $1.4M | $152.7M | $1.5M |
| Total assets | $1.75B | $1.60B | $1.73B | $1.71B | $1.69B | $1.62B | $1.67B | $1.74B | $1.80B | $1.78B | $1.85B | $1.84B |
| Liabilities | ||||||||||||
| Accounts payable | $77.3M | $74.3M | $81.2M | $102.5M | $75.4M | $58.1M | $37.2M | $26.9M | $39.5M | $39.5M | $20.2M | $17.2M |
| Short-term debt | $168.2M | $277.2M | $326.5M | $150.2M | $5.9M | $5.3M | $4.8M | $4.3M | $3.3M | $3.1M | $3.2M | $2.9M |
| Deferred revenue | $700,022 | $6.0M | $11.3M | $23.6M | $33.8M | $40.1M | $47.4M | $63.7M | $75.4M | $63.8M | $53.0M | $630,000 |
| Total current liabilities | $403.6M | $509.1M | $636.4M | $433.6M | $265.5M | $234.4M | $277.6M | $270.9M | $294.3M | $249.7M | $216.4M | $175.2M |
| Long-term debt | $0 | $0 | $0 | $171.9M | $310.3M | $305.7M | $301.2M | $296.6M | $291.6M | $286.4M | $281.3M | $275.9M |
| Lease obligations | $121.8M | $123.3M | $94.6M | $95.4M | $77.6M | $57.1M | $49.4M | $50.0M | $47.4M | $48.3M | $47.3M | $44.6M |
| Other long-term liabilities | $117.7M | $119.9M | $95.2M | $96.2M | $78.6M | $57.8M | $50.8M | $52.2M | $53.3M | $75.0M | $99.5M | $48.6M |
| Total liabilities | $521.3M | $629.0M | $731.6M | $701.7M | $654.4M | $597.9M | $629.6M | $619.7M | $639.2M | $611.0M | $597.2M | $499.7M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $100,003 | $100,003 | $100,000 | $37,000 | $37,000 | $37,000 | $37,000 | $37,000 | $37,000 | $36,000 | $36,000 | $36,000 |
| Retained earnings (deficit) | −$1.98B | −$2.01B | −$1.96B | −$1.93B | −$1.89B | −$1.76B | −$1.66B | −$1.69B | −$1.56B | −$1.54B | −$1.48B | −$1.34B |
| Accumulated other comprehensive income | $194.2M | $199.5M | $122.2M | $115.9M | $116.8M | −$7.4M | −$68.2M | $47.7M | −$14.2M | −$3.7M | $98.9M | $966,000 |
| Total shareholders' equity | $1.23B | $967.7M | $1.00B | $1.01B | $1.04B | $1.02B | $1.04B | $1.12B | $1.16B | $1.16B | $1.25B | $1.34B |
| Key figures | ||||||||||||
| Total debt | $278.2M | $389.3M | $413.7M | $410.2M | $387.9M | $362.8M | $350.6M | $346.6M | $338.9M | $334.7M | $328.7M | $320.5M |
| Net cash (debt) | $686.4M | $445.3M | $534.9M | $582.4M | $579.6M | $642.6M | $772.1M | $865.8M | $952.9M | $967.7M | $980.0M | $1.10B |
| Working capital | $823.8M | $573.6M | $610.7M | $808.4M | $984.4M | $984.4M | $1.01B | $1.08B | $1.13B | $1.16B | $1.28B | $1.33B |
| Tangible book value | $1.18B | $932.7M | $927.5M | $805.0M | $834.8M | $833.1M | $866.3M | $940.6M | $1.01B | $994.6M | $1.25B | $1.20B |
| Book value per share | $6.34 | $5.24 | $5.42 | $5.48 | $5.62 | $5.54 | $5.69 | $6.11 | $6.35 | $6.40 | $6.88 | $7.37 |
| Shares outstanding | 193.8M | 184.7M | 184.7M | 184.6M | 184.1M | 183.8M | 182.9M | 182.7M | 182.6M | 182.0M | 181.9M | 181.8M |
| Current ratio | 3.04 | 2.13 | 1.96 | 2.86 | 4.71 | 5.20 | 4.62 | 4.98 | 4.84 | 5.66 | 6.92 | 8.61 |
| Quick ratio | 2.88 | 2.01 | 1.88 | 2.76 | 4.51 | 5.00 | 4.49 | 4.86 | 4.73 | 5.53 | 6.77 | 8.41 |
| Debt / equity | 0.23 | 0.40 | 0.41 | 0.41 | 0.37 | 0.36 | 0.34 | 0.31 | 0.29 | 0.29 | 0.26 | 0.24 |
| Equity / assets | 70.2% | 60.6% | 57.8% | 59.0% | 61.3% | 63.0% | 62.3% | 64.3% | 64.5% | 65.6% | 67.7% | 72.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 10, 2026); data from EODHD.
LEGN financial position
At the end of fiscal 2025 (December 31, 2025), Legend Biotech had total assets of $1.7 billion (up 3.8% from a year earlier), total liabilities of $731.6 million and shareholders' equity of $1.0 billion. It held $948.6 million in cash and short-term investments against $413.7 million of debt, a net cash position of $534.9 million. Its current ratio was 1.96. In the latest quarter (ended June 30, 2026) total assets were $1.8 billion and equity $1.2 billion.
Related: LEGN income statement, LEGN cash flow statement, LEGN key metrics. See the LEGN stock overview for the latest quote and news.
LEGN balance sheet FAQ
What are Legend Biotech's total assets?
Legend Biotech reported total assets of $1.7 billion at the end of fiscal 2025 (December 31, 2025), compared with $1.7 billion a year earlier.
How much debt does Legend Biotech have?
Legend Biotech had $413.7 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.41.
How much cash does Legend Biotech have?
Legend Biotech held $948.6 million in cash and short-term investments at the end of fiscal 2025; with $413.7 million of debt that is net cash of $534.9 million.
What is Legend Biotech's book value?
Legend Biotech's shareholders' equity (book value) was $1.0 billion at the end of fiscal 2025, or $5.44 per share.
What is Legend Biotech's current ratio?
Legend Biotech had current assets of $1.2 billion and current liabilities of $636.4 million, a current ratio of 1.96 (it can cover its short-term obligations).
How much goodwill does Legend Biotech have?
Legend Biotech carried $74.6 million of goodwill and intangible assets, 4.3% of total assets, at the end of fiscal 2025.